Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ProgynyPGNY +2.38%93 PB Ratio is 4.49 as of Sep. 02, 2026, which is 44% below its 10-year median of 8.07. GuruFocus rates PGNY with a GF Score™ of 93/100 and a GF Value™ of $28.93 (Fairly Valued). The stock has 2 warning signs investors should review. Among 18 Healthcare Plans companies, Progyny ranks worse than 77.78% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-02), Progyny's share price is $26.29. Progyny's Book Value per Share for the quarter that ended in Jun. 2026 was $5.86. Hence, Progyny's PB Ratio of today is 4.49.
The historical rank and industry rank for Progyny's PB Ratio or its related term are showing as below:
PGNY'
s PB Ratio Range Over the Past 10 Years
Min: 2.79 Med: 8.07 Max: 30.64
Current: 4.49
During the past 9 years, Progyny's highest PB Ratio was 30.64. The lowest was 2.79. And the median was 8.07.
PGNY's PB Ratio is ranked worse than 77.78% of 18
companies
in the Healthcare Plans industry
Industry Median: 2.325
vs PGNY: 4.49
During the past 12 months, Progyny's average Book Value Per Share Growth Rate was -2.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 25.50% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Progyny was 44.10% per year. The lowest was 15.30% per year. And the median was 32.65% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Progyny PB Ratio Related Terms
Progyny PB Ratio Historical Data
* Premium members only.
The historical data trend for Progyny's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Progyny's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny PB Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Progyny's PB Ratio distribution charts can be found below:
* The bar in red indicates where Progyny's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Progyny's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Progyny (PGNY) has a PB Ratio of 4.49 as of Sep. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Progyny and its competitors. This is 44% below median its historical median of 8.07. Over the past decade, Progyny's PB Ratio has ranged from 2.79 to 30.64. According to the industry distribution chart, Progyny ranks #14 out of 18 companies in the Healthcare Plans industry, placing it in the top 77.8%.
Is Progyny's PB Ratio too high?
Progyny's current PB Ratio of 4.49 is 44% below median its 10-year median of 8.07. Over the past 10 years, this metric has ranged from a low of 2.79 to a high of 30.64. The Healthcare Plans industry median PB Ratio is 2.33. Progyny's value of 4.49 is 93.1% above this industry median. Based on the distribution chart, Progyny ranks #14 out of 18 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Progyny has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Progyny's PB Ratio compare to CLOV and ALHC?
According to the Healthcare Plans industry distribution chart, Progyny ranks #14 out of 18 companies for PB Ratio. This places Progyny in the lower half of its industry. The industry median PB Ratio is 2.33. Progyny's value of 4.49 is 93.1% above this benchmark. Historically, Progyny's own PB Ratio has ranged from 2.79 to 30.64 over the past decade. While the company's 10-year median is 8.07 vs. the industry median of 2.33, Progyny has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Plans company?
The median PB Ratio among Healthcare Plans companies is 2.33, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Progyny's current PB Ratio of 4.49 is 93.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Progyny and its competitors. For the Healthcare Plans industry, the median PB Ratio is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current PB Ratio is 4.49, which is 44% below median its own 10-year median of 8.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Fairly Valued. The stock's GF Value™ is $28.93, compared to a current price of $26.29 — trading 9.1% below its estimated fair value. The current PB Ratio is 4.49, which is 44% below median its 10-year median of 8.07 and 93.1% above the Healthcare Plans industry median of 2.33. Progyny's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Progyny (PGNY), the current PB Ratio is 4.49 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Progyny (PGNY) Overvalued in 2026?
Based on GuruFocus' analysis, Progyny stock appears to be undervalued.
The current stock price of $26.29 is trading 9.1% below its estimated GF Value™ of $28.93.
GuruFocus considers Progyny to be Fairly Valued.
Key valuation signals for PGNY:
PB Ratio: 4.49 (44% below median its 10-year median of 8.07)
GF Value™: $28.93 vs. price of $26.29 (9.1% below fair value)
Industry Position: 93.1% above the Healthcare Plans median (#14 of 18)
No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
93GF Score
Get the complete analysis for PGNY
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PGNY has been successfully added to your 
